Enable Injections Revenue and Competitors
Estimated Revenue & Valuation
- Enable Injections's estimated annual revenue is currently $67.5M per year.
- Enable Injections received $50.0M in venture funding in October 2018.
- Enable Injections's estimated revenue per employee is $313,750
- Enable Injections's total funding is $347M.
Employee Data
- Enable Injections has 215 Employees.
- Enable Injections grew their employee count by 4% last year.
Enable Injections's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. VP & Program General Manager | Reveal Email/Phone |
2 | SVP, Human Resources & Strategic Growth | Reveal Email/Phone |
3 | VP Product Development and Operations | Reveal Email/Phone |
4 | EVP & COO | Reveal Email/Phone |
5 | EVP, Business Development and CTO | Reveal Email/Phone |
6 | VP, Quality and Regulatory Affairs | Reveal Email/Phone |
7 | VP, Medical/Clinical Affairs | Reveal Email/Phone |
8 | Controller | Reveal Email/Phone |
9 | Director, Engineering Development | Reveal Email/Phone |
10 | Associate Director, Information Technology | Reveal Email/Phone |
Enable Injections Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $470.6M | 1875 | 1% | N/A | N/A |
#2 | $16.3M | 65 | -2% | N/A | N/A |
#3 | $7.8M | 31 | 0% | N/A | N/A |
#4 | $3.8M | 15 | 0% | N/A | N/A |
#5 | $21.1M | 84 | 4% | N/A | N/A |
#6 | $70M | 279 | 8% | N/A | N/A |
#7 | $4M | 16 | -11% | N/A | N/A |
#8 | $135.3M | 539 | 0% | N/A | N/A |
#9 | $11.5M | 46 | 5% | N/A | N/A |
#10 | $8.8M | 35 | 35% | N/A | N/A |
What Is Enable Injections?
Enable Injections, Inc. Enable Injections is pioneering a new class of drug delivery technology, the wearable high-volume injector, that industry experts are calling truly revolutionary. Winner of Buzz of BIO Investor Forum and other accolades, the Enable Injections technology is designed to allow easy, comfortable self-administration of the more than 900 high volume, viscous biologics in development--promising new drugs to treat a host of conditions from cancers and autoimmune diseases to genetic and rare diseases that, because of the large doses required, cannot be delivered with today's legacy injection technology. Founded in 2010 by medical device industry veterans, the company has R&D and manufacturing facilities in Franklin, Ohio. More at www.enableinjections.com About Enable Injections Enable Injections develops and manufactures devices that allow easy, comfortable patient self-administration of high volume/viscosity drugs for pharmaceutical and biotechnology industry*. The Enable body-worn Injector utilizes any standard container closure system, including syringe, vial or cartridge; automatically warms and can automatically mix lyophilized solutions. Founded February 2010 by medical device industry veterans, the company has R&D and manufacturing facilities in Franklin, Ohio. Please visit www.enableinjections.com. *Currently for investigational use only
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals$347M
Total Funding
215
Number of Employees
$67.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Enable Injections News
On-body Injectors Market Size, Outlook And Forecast | BD Medical, Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche,...
... Sensile Medical AGInsulet Corporation, Enable Injections, Becton, ... Verified Market Intelligence is our BI-enabled platform for...
Mike Hooven is the CEO and founder of Enable Injections Inc. ... A red-hot Cincinnati startup is at the center of a new $300 million-plus...
Genentech enters a manufacturing and development agreement with Enable Injections to advance the latter's patient-administered ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $77.9M | 216 | 0% | N/A |
#2 | $43M | 217 | N/A | N/A |
#3 | $15M | 222 | 0% | N/A |
#4 | $35.6M | 223 | 10% | N/A |
#5 | $35.7M | 224 | 25% | N/A |
Enable Injections Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2016-08-08 | $5.0M | Undisclosed | Article | |
2016-10-05 | $30.0M | A | ORI Healthcare Fund | Article |
2018-10-26 | $50.0M | B | Sanofi | Article |